NEW YORK (GenomeWeb News) – GenMark Diagnostics said after the close of the market on Wednesday that revenues for its second quarter increased 44 percent year over year with strong growth in reagent and instrument revenues.

For the three months ended June 30, total revenues rose to $5.2 million from $3.6 million and beat the average Wall Street estimate of $5.1 million. The increase, GenMark said, "reflects an increase in the number of systems placed at customer sites, growth in test menus, and an increase in the number of tests sold."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.

By studying the spectra of microbes on Earth, a team of researchers hopes to be better equipped to detect any on other worlds.

SolveBio's Mark Kaganovich says at TechCrunch that genomics needs an app to push it into the mainstream.

A University of Michigan team is using a Facebook app to recruit and keep in touch with participants in its 'Genes for Good' project.